BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Experts in dermatology, medical aesthetics, tissue engineering - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.rbcconsultants.com
X-WR-CALDESC:Events for Experts in dermatology, medical aesthetics, tissue engineering
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251030T190000
DTEND;TZID=America/New_York:20251030T200000
DTSTAMP:20260415T162213
CREATED:20251025T123218Z
LAST-MODIFIED:20251025T123218Z
UID:1434-1761850800-1761854400@www.rbcconsultants.com
SUMMARY:Now Approved: A new path forward with RHAPSIDO® (remibrutinib)
DESCRIPTION:Speaker: David Cotter\, MD\, PhD Medical Director\, Lakes Dermatology Fellow\, American Academy of Dermatology  Vice President and Director of Clinical Research Assistant Clinical Professor of Medicine and Dermatology University of Nevada Las Vegas Las Vegas\, Nevada \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: Now Approved: A new path forward with RHAPSIDO® (remibrutinib) In this program\, you’ll gain the tools to: – Recognize when to consider escalation of therapy – Understand the unique mechanism of action of RHAPSIDO® – Identify patients in your practice who may be ready for RHAPSIDO® \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/now-approved-a-new-path-forward-with-rhapsido-remibrutinib/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251022T190000
DTEND;TZID=America/New_York:20251022T200000
DTSTAMP:20260415T162213
CREATED:20251016T121410Z
LAST-MODIFIED:20251016T121410Z
UID:1431-1761159600-1761163200@www.rbcconsultants.com
SUMMARY:Clinical Insights Across the Skin and Joints
DESCRIPTION:Speaker: Joe K. Tung\, MD\, MBA\, FAAD Director\, Clinical Trials Unit Medical Director\, Falk Dermatology Associate Director\, Dermatology Residency Program Department of Dermatology University of Pittsburgh Medical Center \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: Shared Pathways: Clinical Insights Across the Skin and Joints \nPLEASE CLICK HERE TO REGISTER \n 
URL:https://www.rbcconsultants.com/event/clinical-insights-across-the-skin-and-joints/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251016T200000
DTEND;TZID=America/New_York:20251016T210000
DTSTAMP:20260415T162213
CREATED:20250925T233648Z
LAST-MODIFIED:20250925T233648Z
UID:1417-1760644800-1760648400@www.rbcconsultants.com
SUMMARY:Vitiligo Real-World Case Studies
DESCRIPTION:Speaker: Karan Lal\, DO Director of Pediatric Dermatology and Cosmetic Surgery Affiliated Dermatology \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another International Dermatology Education Foundation Series Webinar: Vitiligo Real-World Case Studies. This is an educational program brought to you by Incyte Dermatology. Webinar Objectives: – Review cases of real-world nonsegmental vitiligo patients treated with a topical treatment option – Review clinical trial data supporting the use of a topical treatment option in nonsegmental vitiligo patients – Discuss clinical pearls to help effectively manage your nonsegmental vitiligo patients \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/vitiligo-real-world-case-studies/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251014T190000
DTEND;TZID=America/New_York:20251014T200000
DTSTAMP:20260415T162213
CREATED:20251009T152913Z
LAST-MODIFIED:20251009T152913Z
UID:1429-1760468400-1760472000@www.rbcconsultants.com
SUMMARY:RYBREVANT® (amivantamab-vmjw) + LAZCLUZE® (lazertinib) Proactive Strategies to Help Patients
DESCRIPTION:Please join us for our next ODS Educational Series Webinar: RYBREVANT® (amivantamab-vmjw) + LAZCLUZE® (lazertinib) Proactive Strategies to Help Patients on Therapy. Take part in a deep dive into prophylactic approaches associated with RYBREVANT® + LAZCLUZE® treatment and gain insights about efficacy and safety. Please read full Prescribing Information for RYBREVANT® (https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/RYBREVANT-pi.pdf) and full Prescribing Information for LAZCLUZE® (https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/LAZCLUZE-pi.pdf). \nModerator: Mario E. Lacouture\, MD\, FAAD Founding President\, Oncodermatology Society Chief\, Dermatology Division\, Department of Medicine NYU Grossman Long Island School of Medicine Medical Director\, Symptom Management Program Perlmutter Cancer Center NYU Langone Hospital – Long Island \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/rybrevant-amivantamab-vmjw-lazcluze-lazertinib-proactive-strategies-to-help-patients/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251014T190000
DTEND;TZID=America/New_York:20251014T200000
DTSTAMP:20260415T162213
CREATED:20251007T162520Z
LAST-MODIFIED:20251007T162520Z
UID:1425-1760468400-1760472000@www.rbcconsultants.com
SUMMARY:Demand More with Bimzelx
DESCRIPTION:Speaker: Christopher Sayed\, MD Professor\, Department of Dermatology University of North Carolina Chapel Hill\, North Carolina \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/demand-more-with-bimzelx/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251013T190000
DTEND;TZID=America/New_York:20251013T200000
DTSTAMP:20260415T162213
CREATED:20250925T233510Z
LAST-MODIFIED:20250925T233527Z
UID:1415-1760382000-1760385600@www.rbcconsultants.com
SUMMARY:Transform Your Patient’s Journey. Adbry®: Early Itch Relief and Long-Term Disease Control
DESCRIPTION:Speaker: Angela Lamb\, MD Dermatology System Vice Chair Clinical Operations and Strategy Icahn School of Medicine Mount Sinai Hospital New York\, NY \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nCLICK HERE TO REGISTER \n 
URL:https://www.rbcconsultants.com/event/transform-your-patients-journey-adbry-early-itch-relief-and-long-term-disease-control/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251009T213000
DTEND;TZID=America/New_York:20251009T223000
DTSTAMP:20260415T162213
CREATED:20250930T223337Z
LAST-MODIFIED:20250930T223337Z
UID:1421-1760045400-1760049000@www.rbcconsultants.com
SUMMARY:Advancing Patient Care in Vitiligo:  Insights and Practical Management Strategies
DESCRIPTION:Speakers: Erik Domingues\, MD\, FAAD Modern Dermatology of Massachusetts Erika Page Founder/CEO\, Living Dappled \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another International Dermatology Education Foundation Series Webinar: Advancing Patient Care in Vitiligo: Insights and Practical Management Strategies. This is an educational program brought to you by Incyte Dermatology. Please join us for an expert-led discussion on the pathophysiology of vitiligo\, challenges in disease management\, goals of therapy\, and best practices for patient communication and shared decision-making. We will also gain perspectives from a patient living with vitiligo\, to better understand the impact of disease and how to support shared decision-making. \nPlease note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Incyte Corporation and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses\, guests\, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal\, state or local laws or government ethics restrictions may not attend. \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/advancing-patient-care-in-vitiligo-insights-and-practical-management-strategies/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251006T190000
DTEND;TZID=America/New_York:20251006T200000
DTSTAMP:20260415T162213
CREATED:20250916T010631Z
LAST-MODIFIED:20250916T010631Z
UID:1412-1759777200-1759780800@www.rbcconsultants.com
SUMMARY:A New Treatment for Adults With Severe Alopecia Areata: LEQSELVI™ (Deuruxolitinib) 8mg
DESCRIPTION:Speaker: Naiem Issa\, MD\, PHD Medical Director of Clinical Trials and Research\, Forefront Dermatology Adjunct Professor\, George Washington University School of Medicine and Health Sciences Voluntary Assistant Professor\, University of Miami Leonard M. Miller School of Medicine Clinical Instructor\, West Virginia School of Osteopathic Medicine \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: A New Treatment for Adults With Severe Alopecia Areata: LEQSELVI™ (Deuruxolitinib) 8mg — Full Speed A Head. \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/a-new-treatment-for-adults-with-severe-alopecia-areata-leqselvi-deuruxolitinib-8mg-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250930T190000
DTEND;TZID=America/New_York:20250930T200000
DTSTAMP:20260415T162213
CREATED:20250916T010411Z
LAST-MODIFIED:20250916T010411Z
UID:1410-1759258800-1759262400@www.rbcconsultants.com
SUMMARY:Taltz for Today and Tomorrow
DESCRIPTION:Speaker: Pranav B. Sheth\, MD\, FAAD Board-Certified Dermatologist Dermatology & Skin Care Associates Volunteer Associate Professor of Dermatology University of Cincinnati College of Medicine \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nDr. Sheth has a background in both academic medicine and clinical dermatology. He has been an investigator in over 120 clinical trials\, teaches at the University of Cincinnati Department of Dermatology\, and is currently in a private practice in West Chester Ohio. He has publications in peer reviewed journals and has chapters in various books on psoriasis\, therapeutics\, and vitiligo. He is past president of the Cincinnati Dermatological Society\, and current Chair of the Scientific Poster Judging committee for the Ohio Dermatological Association. He has been voted in the list of Best Doctors by Cincinnati Magazine for the last 15+ years. His wife is a pediatric dermatologist in Cincinnati\, and his daughter is a Chief Resident in dermatology at Northwestern. Dr. Sheth loves teaching. \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/taltz-for-today-and-tomorrow/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250929T190000
DTEND;TZID=America/New_York:20250929T200000
DTSTAMP:20260415T162213
CREATED:20250827T163922Z
LAST-MODIFIED:20250827T163922Z
UID:1402-1759172400-1759176000@www.rbcconsultants.com
SUMMARY:A Joint Approach to Psoriatic Disease Management: Bimzelx for your patients with PSO & PSA
DESCRIPTION:Speakers: Evan Siegel MD\, FACP\, MACR Senior Partner\, Arthritis and Rheumatism Associates Clinical Professor of Medicine Georgetown University School of Medicine Ben Lockshin MD\, FAAD Board‑Certified Dermatologist\, U.S. Dermatology Partners Director\, Clinical Trials Center at U.S. Dermatology Partners \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nPlease join us for our next IDEF Educational Series Webinar: A Joint Approach to Psoriatic Disease Management: Bimzelx for your patients with PSO & PSA. \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/a-joint-approach-to-psoriatic-disease-management-bimzelx-for-your-patients-with-pso-psa/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250925T200000
DTEND;TZID=America/New_York:20250925T210000
DTSTAMP:20260415T162213
CREATED:20250823T143041Z
LAST-MODIFIED:20250823T143041Z
UID:1400-1758830400-1758834000@www.rbcconsultants.com
SUMMARY:Mild to Moderate Atopic Dermatitis:  Burden of Disease and a Topical Pathway
DESCRIPTION:Speaker: Douglas Kress\, MD Chief of the Division of Pediatric Dermatology UPMC Children’s Hospital of Pittsburgh \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another International Dermatology Education Foundation Series Webinar: Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway. This is an educational program brought to you by Incyte Dermatology. Webinar Objectives: – Review the evolving understanding of atopic dermatitis (AD)\, diagnosis\, management\, and the patient journey – Evaluate a treatment option for mild to moderate AD – Understand the indicated patient population for treatment \nCLICK HER TO REGISTER \n 
URL:https://www.rbcconsultants.com/event/mild-to-moderate-atopic-dermatitis-burden-of-disease-and-a-topical-pathway-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250924T190000
DTEND;TZID=America/New_York:20250924T200000
DTSTAMP:20260415T162213
CREATED:20250916T010229Z
LAST-MODIFIED:20250916T010229Z
UID:1408-1758740400-1758744000@www.rbcconsultants.com
SUMMARY:A Breakthrough for Hands That Need to Get UP and GO Introducing ANZUPGO
DESCRIPTION:Speaker: Lindsay Ackerman\, MD President Medical Dermatology Specialists Phoenix\, AZ\nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY\n\n\n\nPlease join us for our next IDEF Educational Series Webinar: A Breakthrough for Hands That Need to Get UP and GO Introducing ANZUPGO®: The FIRST and ONLY FDA-Approved Treatment for Moderate to Severe CHE\n\nREGISTER HERE
URL:https://www.rbcconsultants.com/event/a-breakthrough-for-hands-that-need-to-get-up-and-go-introducing-anzupgo/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250902T190000
DTEND;TZID=America/New_York:20250902T200000
DTSTAMP:20260415T162213
CREATED:20250813T184158Z
LAST-MODIFIED:20250813T184254Z
UID:1395-1756839600-1756843200@www.rbcconsultants.com
SUMMARY:Explore EBGLYSS®(lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression
DESCRIPTION:Speaker: Jeffrey LaDuca\, MD Founder Reflections Dermatology and Psoriasis Center New York\, New York Dr. LaDuca earned his undergraduate degree in biology from LeMoyne College in Syracuse\, NY. After beginning his graduate studies at Penn State University\, Dr. LaDuca earned his PhD in physiology from Roswell Park Cancer Institute in Buffalo\, NY. Dr. LaDuca completed his medical degree at SUNY at Syracuse. After completing an internship in Internal Medicine in Syracuse\, Dr. LaDuca completed his residency in Dermatology at The University of Rochester. It was during these years that Dr. LaDuca became interested in psoriasis and inflammatory skin conditions and was involved in clinical trials for some of the first biologic agents. Dr. LaDuca is the founder and managing partner of Reflections Dermatology and Psoriasis Center with three offices open in central New York. He continues to contribute to peer-reviewed journals\, teach residents\, medical and PA/NP students and lecture extensively about the use of biologics in dermatology. \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nPlease join us for our next IDEF Educational Series Webinar: Explore EBGLYSS®(lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression. Join us for “Explore EBGLYSS® (lebrikizumab-lbkz)”\, where Jeffrey LaDuca\, MD will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data\, safety\, dosing information\, and how to get patients started on EBGLYSS. \n  \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/explore-ebglysslebrikizumab-lbkz-see-how-ebglyss-can-leave-a-lasting-impression/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250819T190000
DTEND;TZID=America/New_York:20250819T200000
DTSTAMP:20260415T162213
CREATED:20250813T184042Z
LAST-MODIFIED:20250813T184323Z
UID:1393-1755630000-1755633600@www.rbcconsultants.com
SUMMARY:Unlocking Chronic Spontaneous Urticaria (CSU): Exploring the Role of Bruton’s tyrosine kinase (BTK)
DESCRIPTION:Speaker: Jason Hawkes\, MD\, MS Clinical Assistant Professor of Dermatology\, Oregon Health & Science University Portland\, OR \n  \nModerator: Leon Kircik\, MD\, FAAD Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Adjunct Clinical Professor of Dermatology Indiana University School of Medicine\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another IDEF Educational Series Webinar: Unlocking Chronic Spontaneous Urticaria (CSU): Exploring the Role of Bruton’s tyrosine kinase (BTK) in Pathophysiology\, Unmet Needs\, and Disease Burden. This presentation offers a revealing look at chronic spontaneous urticaria (CSU)\, centered on two key aspects: the role of Bruton’s tyrosine kinase (BTK) as a mediator of FcεRI mast cell degranulation in its pathophysiology\, and the profound impact CSU symptoms can have on patients’ lives. \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/unlocking-chronic-spontaneous-urticaria-csu-exploring-the-role-of-brutons-tyrosine-kinase-btk/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250814T190000
DTEND;TZID=America/New_York:20250814T200000
DTSTAMP:20260415T162213
CREATED:20250805T192236Z
LAST-MODIFIED:20250805T192236Z
UID:1390-1755198000-1755201600@www.rbcconsultants.com
SUMMARY:Transformative Treatment Results in Plaque Psoriasis and Psoriatic Arthritis
DESCRIPTION:Speaker: Marc Serota\, MD Practicing Physician Peak Dermatology Littleton\, CO CEO\, MD Integrations Quadruple Board Certified Dermatology\, Allergy/Asthma/Immunology\, Pediatrics\, and Obesity Medicine\n\n\n\nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY\n\nPlease join us for our next IDEF Educational Series Webinar: Transformative Treatment Results in Plaque Psoriasis and Psoriatic Arthritis.\n\nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/transformative-treatment-results-in-plaque-psoriasis-and-psoriatic-arthritis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250731T190000
DTEND;TZID=America/New_York:20250731T200000
DTSTAMP:20260415T162213
CREATED:20250714T133519Z
LAST-MODIFIED:20250714T133556Z
UID:1385-1753988400-1753992000@www.rbcconsultants.com
SUMMARY:A New Treatment for Adults With Severe Alopecia Areata: LEQSELVI™ (Deuruxolitinib) 8mg
DESCRIPTION:Speaker: Chesahna Kindred\, MD\, MBA\, FAAD Owner and Dermatologist Kindred Hair and Skin \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nPlease join us for our next IDEF Educational Series Webinar: A New Treatment for Adults With Severe Alopecia Areata: LEQSELVI™ (Deuruxolitinib) 8mg — Full Speed A Head.
URL:https://www.rbcconsultants.com/event/a-new-treatment-for-adults-with-severe-alopecia-areata-leqselvi-deuruxolitinib-8mg-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250722T190000
DTEND;TZID=America/New_York:20250722T200000
DTSTAMP:20260415T162213
CREATED:20250714T145503Z
LAST-MODIFIED:20250714T145609Z
UID:1387-1753210800-1753214400@www.rbcconsultants.com
SUMMARY:An Option to Choose TREMFYA First
DESCRIPTION:Speaker: Mona Shahriari\, MD Associate Clinical Professor of Dermatology\, Yale University Associate Director of Clinical Trials\, CCD Research \nModerator: Leon Kircik\, MD\, FAAD Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Adjunct Clinical Professor of Dermatology Indiana University School of Medicine\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another IDEF Educational Series Webinar: An Option to Choose TREMFYA First.
URL:https://www.rbcconsultants.com/event/an-option-to-choose-tremfya-first/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250715T200000
DTEND;TZID=America/New_York:20250715T210000
DTSTAMP:20260415T162213
CREATED:20250617T123649Z
LAST-MODIFIED:20250617T123649Z
UID:1379-1752609600-1752613200@www.rbcconsultants.com
SUMMARY:Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway
DESCRIPTION:Speaker: Lisa Swanson\, MD Pediatric Dermatologist Ada West Dermatology \nJoin us for another International Dermatology Education Foundation Series Webinar: Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway. This is an educational program brought to you by Incyte Dermatology. Webinar Objectives: – Review the evolving understanding of atopic dermatitis (AD)\, diagnosis\, management\, and the patient journey – Evaluate a treatment option for mild to moderate AD – Understand the indicated patient population for treatment \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nCLICK HERE TO REGISTER \n 
URL:https://www.rbcconsultants.com/event/mild-to-moderate-atopic-dermatitis-burden-of-disease-and-a-topical-pathway/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250626T190000
DTEND;TZID=America/New_York:20250626T200000
DTSTAMP:20260415T162213
CREATED:20250624T131909Z
LAST-MODIFIED:20250624T131909Z
UID:1382-1750964400-1750968000@www.rbcconsultants.com
SUMMARY:A New Treatment for Adults With Severe Alopecia Areata: LEQSELVI™ (Deuruxolitinib) 8mg
DESCRIPTION:Speaker: Natasha Atanaskova Mesinkovska\, MD\, PhD Vice Chair Dermatology Clinical Research University of California Irvine \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/a-new-treatment-for-adults-with-severe-alopecia-areata-leqselvi-deuruxolitinib-8mg/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250623T190000
DTEND;TZID=America/New_York:20250623T200000
DTSTAMP:20260415T162213
CREATED:20250529T162405Z
LAST-MODIFIED:20250609T124956Z
UID:1375-1750705200-1750708800@www.rbcconsultants.com
SUMMARY:The First Triple-Combination Topical for Acne ⏤ Breaking Ground in Treatment
DESCRIPTION:Speaker: Seemal Desai\, MD\, FAAD Founder & Medical Director Innovative Dermatology Clinical Associate Professor Department of Dermatology Universoty of Texas Southwestern Medical Center \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nAttendees will have the opportunity to pose questions to the speaker about the data presented. This program is sponsored by Ortho Dermatologics and is being presented consistent with FDA guidelines and is not approved for continuing education credit. \nJoin us for another IDEF Educational Series Webinar: The First Triple-Combination Topical for Acne ⏤ Breaking Ground in Treatment. \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/the-first-triple-combination-topical-for-acne-%e2%8f%a4-breaking-ground-in-treatment/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250610T190000
DTEND;TZID=America/New_York:20250610T200000
DTSTAMP:20260415T162213
CREATED:20250529T162159Z
LAST-MODIFIED:20250529T162159Z
UID:1373-1749582000-1749585600@www.rbcconsultants.com
SUMMARY:Getting Started: The Lilly & EBGLYSS™ (lebrikizumab-lbkz) Support Experience
DESCRIPTION:Speaker: DeNae Norman Biotechnology Professional Pharmacy Technician \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nThis program will provide a tailored overview of Lilly Support Services for EBGLYSS and how to get patients started on EBGLYSS\, with a focus on access\, enrollment\, and quick start treatment processes. \nPlease join us for our next IDEF Educational Series Webinar: Getting Started: The Lilly & EBGLYSS™ (lebrikizumab-lbkz) Support Experience. \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/getting-started-the-lilly-ebglyss-lebrikizumab-lbkz-support-experience/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250605T213000
DTEND;TZID=America/New_York:20250605T223000
DTSTAMP:20260415T162213
CREATED:20250529T015417Z
LAST-MODIFIED:20250529T125023Z
UID:1363-1749159000-1749162600@www.rbcconsultants.com
SUMMARY:Vitiligo: Achieving and Maintaining Repigmentation
DESCRIPTION:Speaker: \nSeemal Desai\, MD\, FAAD Innovative Dermatology The University of Texas Southwestern Medical Center Plano\, Texas \n\nWebinar Objectives:  \n– Review clinical features of vitiligo\, disease prevalence\, treatment considerations\, and the patient experience \n– Discuss the mechanism of action and formulation for a topical treatment option for nonsegmental vitiligo \n– Evaluate the safety and efficacy data for a topical treatment option in the treatment of nonsegmental vitiligo \n  \nModerator: \nLeon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nJoin us for another International Dermatology Education Foundation Series Webinar: Vitiligo: Achieving and Maintaining Repigmentation. This is an educational program brought to you by Incyte Dermatology. \n  \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/vitiligo-achieving-and-maintaining-repigmentation/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250603T190000
DTEND;TZID=America/New_York:20250603T200000
DTSTAMP:20260415T162213
CREATED:20250529T161858Z
LAST-MODIFIED:20250529T161858Z
UID:1371-1748977200-1748980800@www.rbcconsultants.com
SUMMARY:Clinical Data and Patient Photos on an Oral Treatment Option for Adults with Plaque Psoriasis
DESCRIPTION:Speaker: Raj Chovatiya\, MD\, PhD\, MSCI\, FAAD Clinical Associate Professor Rosalind Franklin University Chicago Medical School Founder and Director Center for Medical Dermatology + Immunology Research Chicago\, Illinois \nThe program will provide an up-to-date overview with data through 5 years\, including in patients with scalp involvement\, safety data\, and dosing and administration. This event is sponsored by Bristol Myers Squibb\, and the speaker is a paid consultant of Bristol Myers Squibb. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance. \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nPlease join us for a discussion that focuses on an oral treatment option for adults with moderate-to-severe plaque psoriasis. \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/clinical-data-and-patient-photos-on-an-oral-treatment-option-for-adults-with-plaque-psoriasis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250529T190000
DTEND;TZID=America/New_York:20250529T200000
DTSTAMP:20260415T162213
CREATED:20250529T013741Z
LAST-MODIFIED:20250529T125114Z
UID:1359-1748545200-1748548800@www.rbcconsultants.com
SUMMARY:Clinical Updates for WINLEVI (clascoterone) Cream 1%
DESCRIPTION:Speaker: Hilary E. Baldwin\, MD\, FAAD The Acne Treatment and Research Center Rutgers Robert Wood Johnson Medical Center New York\, New York \n  \nDr. Baldwin will review updated data on WINLEVI® (clascoterone) Cream 1%. New data will include the effect WINLEVI has on the skin barrier\, a consideration when selecting a therapeutic approach for your patients. \nModerator:  \nLeon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another International Dermatology Education Foundation Series Webinar: Clinical Updates for WINLEVI® (clascoterone) Cream 1%. \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/clinical-updates-for-winlevi-clascoterone-cream-1/
END:VEVENT
END:VCALENDAR